Cargando…
Histone deacetylase 10, a potential epigenetic target for therapy
Histone deacetylase (HDAC) 10, a class II family, has been implicated in various tumors and non-tumor diseases, which makes the discovery of biological functions and novel inhibitors a fundamental endeavor. In cancers, HDAC10 plays crucial roles in regulating various cellular processes through its e...
Autores principales: | Cheng, Fajuan, Zheng, Bin, Wang, Jianwei, Zhao, Guiting, Yao, Zhongshun, Niu, Zhihong, He, Wei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Portland Press Ltd.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8182986/ https://www.ncbi.nlm.nih.gov/pubmed/33997894 http://dx.doi.org/10.1042/BSR20210462 |
Ejemplares similares
-
Comprehensive analysis of a new prognosis signature based on histone deacetylases in clear cell renal cell carcinoma
por: Cheng, Fajuan, et al.
Publicado: (2021) -
The Roles of CircRNAs in Bladder Cancer: Biomarkers, Tumorigenesis Drivers, and Therapeutic Targets
por: Cheng, Fajuan, et al.
Publicado: (2021) -
Comprehensive analysis of new prognostic signature based on ferroptosis-related genes in clear cell renal cell carcinoma
por: Zheng, Bin, et al.
Publicado: (2021) -
NUPR1 is a novel potential biomarker and confers resistance to sorafenib in clear cell renal cell carcinoma by increasing stemness and targeting the PTEN/AKT/mTOR pathway
por: He, Wei, et al.
Publicado: (2021) -
Integrative Analysis of Immune-Related Genes in the Tumor Microenvironment of Renal Clear Cell Carcinoma and Renal Papillary Cell Carcinoma
por: Zheng, Bin, et al.
Publicado: (2021)